Single Nucleotide Polymorphisms in the u-PA Gene are Related to Susceptibility to Oral Tongue Squamous Cell Carcinoma in the Northern Chinese Han Population |
Zhong, Feng
(Department of Oral and Maxillofacial Surgery, The Affiliated Hospital of Medical College, Qingdao University)
Yang, Xue-Cai (Department of Oral and Maxillofacial Surgery, The Affiliated Hospital of Medical College, Qingdao University) Bu, Ling-Xue (Department of Oral and Maxillofacial Surgery, The Affiliated Hospital of Medical College, Qingdao University) Li, Ning-Yi (Department of Oral and Maxillofacial Surgery, The Affiliated Hospital of Medical College, Qingdao University) Chen, Wan-Tao (Department of Oral and Maxillofacial Surgery, College of Stomatology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine) |
1 | Andreasen PA, Georg B, Lund LR, Riccio A, Stacey SN (1990). Plasminogen activator inhibitors: hormonally regulated serpins. Mol Cell Endocrinol, 68, 1-19. DOI ScienceOn |
2 | Andreasen PA, Kjoller L, Christensen L, Duffy MJ (1997). The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer, 72, 1-22. DOI ScienceOn |
3 | Chapman HA (1997). Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol, 9, 714-24. DOI ScienceOn |
4 | Conese M, Blasi F (1995). The urokinase/urokinase-receptor system and cancer invasion. Baillieres Clin Haematol, 8, 365-89. DOI |
5 | Deng G, Curriden SA, Wang S, Rosenberg S, Loskutoff DJ (1996). Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptormediated cell adhesion and release? J Cell Biol, 134, 1563-71. DOI |
6 | Franceschi D, Gupta R, Spiro RH, Shah JP (1993). Improved survival in the treatment of squamous carcinoma of the oral tongue. Am J Surg, 166, 360-5. DOI ScienceOn |
7 | Kanse S, Kost C, Wilhelm O, Andreasen PA, Preissner KT (1996). The urokinase receptor is a major vitronectin-binding protein on endothelial cells. Exp Cell Res, 224, 344-53. DOI ScienceOn |
8 | Lippman SM, Sudbo J, Hong WK (2005). Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol, 23, 346-56. DOI ScienceOn |
9 | Mignatti P, Rifkin DB (1993). Biology and biochemistry of proteases in tumor invasion. Physiol Rev, 73, 161-95. |
10 | Myoung H, Hong SP, Yun PY, Lee JH, Kim MJ (2003). Anti-cancer effect of genistein in oral squamous cell carcinoma with respect to angiogenesis and in vitro invasion. Cancer Sci, 94, 215-20. DOI ScienceOn |
11 | Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. DOI ScienceOn |
12 | Schmitt M, Harbeck N, Thomssen C, et al (1997). Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thromb Haemost, 78, 285-96. |
13 | Shi YY, He L (2005). SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res, 15, 97-8. DOI ScienceOn |
14 | Stefansson S, Lawrence DA (1996). The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature, 383, 441-3. DOI ScienceOn |
15 | Stoppelli MP, Corti A, Soffientini A, Cassani G, Blasi F, Assoian RK (1985). Differentiation enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc Natl Acad Sci USA, 82, 4939-43. DOI ScienceOn |
16 | Sudbo J, Reith A (2005). The evolution of predictive oncology and molecular-based therapy for oral cancer prevention. Int J Cancer, 115, 339-45. DOI ScienceOn |
17 | TerwilligerJD, Ott J (1994). Handbook of Human Genetic Linkage. John Hopkins University Press, New York. |
18 | Vassalli JD, Baccino D, Berlin D (1985). A cellular binding site for the Mr 55,000 form of the human plasminogen activator urokinase. J Cell Biol, 100, 86-92. DOI ScienceOn |
19 | Wei Y, Lukashev M, Simon DI, et al (1996). Regulation of integrin function by the urokinase receptor. Science, 273, 1551-5. DOI ScienceOn |
20 | Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA (1994). Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem, 269, 32380-8. |
21 | Xie X, Ott J (1993). Testing linkage disequilibrium between a disease gene and marker loci. Am J Hum Genet, 53, 1107. |
22 | Zhang Z, Pan J, Li L, Wang Z, Xiao W, Li N (2011). Survey of risk factors contributed to lymphatic metastasis in patients with oral tongue cancer by immunohistochemistry. J Oral Pathol Med, 40, 127-34. DOI ScienceOn |